Budipine
| Title | Journal |
|---|---|
| Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). | Movement disorders : official journal of the Movement Disorder Society 20110101 |
| [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. | Fortschritte der Neurologie-Psychiatrie 20100301 |
| A new strategy for antidepressant prescription. | Frontiers in neuroscience 20100101 |
| Paradoxical aspects of parkinsonian tremor. | Movement disorders : official journal of the Movement Disorder Society 20080130 |
| Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats. | Brain research 20061030 |
| Budipine in Parkinson's tremor. | Journal of the neurological sciences 20061025 |
| [Diagnosis and therapy of idiopathic Parkinson's disease]. | MMW Fortschritte der Medizin 20060515 |
| Efficacy and safety of high-dose cabergoline in Parkinson's disease. | Acta neurologica Scandinavica 20060101 |
| Efficacy of budipine and placebo in untreated patients with Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20050801 |
| Pharmacotherapy of Parkinson's disease in Germany. | Journal of neurology 20050801 |
| Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats. | British journal of pharmacology 20050701 |
| The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice. | Neuroscience letters 20050701 |
| Synergism between topiramate and budipine in refractory status epilepticus in the rat. | Epilepsia 20041101 |
| Antiapoptotic effects of budipine. | Journal of neural transmission (Vienna, Austria : 1996) 20041001 |
| Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine. | Naunyn-Schmiedeberg's archives of pharmacology 20031101 |
| Evaluation of possible pro- or antioxidative properties and of the interaction capacity with the microsomal cytochrome P450 system of different NMDA-receptor ligands and of taurine in vitro. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20030601 |
| [Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?]. | MMW Fortschritte der Medizin 20030526 |
| [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]. | MMW Fortschritte der Medizin 20020506 |
| Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen. | Archives of neurology 20020501 |
| Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. | Current drug targets 20010901 |
| Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. | Pharmacogenetics 20010801 |
| Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration. | International journal of clinical pharmacology and therapeutics 20010601 |
| Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. | Movement disorders : official journal of the Movement Disorder Society 20010501 |
| Non-dopaminergic drug treatment of Parkinson's disease. | Expert opinion on pharmacotherapy 20010401 |
| [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine]. | Fortschritte der Neurologie-Psychiatrie 20010201 |
| Workshop IV: drug treatment guidelines for the long-term management of Parkinson's disease. | Journal of neurology 20000901 |
| Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. | European psychiatry : the journal of the Association of European Psychiatrists 19991001 |
| [Synthesis, physical-chemical properties and pharmacologically-oriented screening studies on budipine and related 4,4-diphenylpiperidines]. | Arzneimittel-Forschung 19840101 |